Cimpress (CMPR) Financials

$42.92 -0.59 (-1.36%)

Closing price 04:00 PM Eastern

Extended Trading

$42.84 -0.08 (-0.19%)

As of 04:20 PM Eastern

Annual Income Statements for Cimpress

This table shows Cimpress' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	43	92	54	-72	44	95	83	-85	-54	-186	174
Consolidated Net Income / (Loss)	43	89	50	-72	47	93	84	-82	-51	-186	178
Net Income / (Loss) Continuing Operations	43	89	50	-72	47	93	185	-82	-51	-186	178
Total Pre-Tax Income	57	100	66	-79	66	127	3.00	-64	9.33	-30	128
Total Operating Income	86	96	78	-46	158	164	56	124	47	57	247
Total Gross Profit	819	926	1,014	1,098	1,313	1,350	1,232	1,276	1,395	1,439	1,597
Total Revenue	1,270	1,494	1,788	2,135	2,593	2,751	2,481	2,576	2,888	3,080	3,292
Operating Revenue	1,270	1,494	1,788	2,135	2,593	2,751	2,481	2,576	2,888	3,080	3,292
Total Cost of Revenue	451	569	774	1,037	1,280	1,401	1,249	1,300	1,493	1,641	1,695
Operating Cost of Revenue	451	569	774	1,037	1,280	1,401	1,249	1,300	1,493	1,641	1,695
Total Operating Expenses	733	829	936	1,144	1,155	1,186	1,076	1,153	1,348	1,382	1,349
Selling, General & Admin Expense	117	143	146	208	177	163	183	196	197	209	206
Marketing Expense	440	472	509	611	715	714	574	648	789	774	790
Research & Development Expense	176	187	210	243	246	237	253	253	293	302	322
Amortization Expense	-	24	41	46	50	53	52	54	54	47	31
Impairment Charge	0.00	0.00	31	9.56	0.00	7.50	-	0.00	0.00	5.61	0.00
Restructuring Charge	-	3.20	0.38	27	15	12	14	1.64	14	44	0.42
Total Other Income / (Expense), net	-29	3.43	-12	-34	-91	-37	-53	-187	-38	-88	-119
Interest Expense	7.67	17	38	44	70	63	76	168	99	106	120
Other Income / (Expense), net	-22	20	26	10	-21	26	23	-19	61	18	1.58
Income Tax Expense	11	10	16	-7.12	20	33	-81	19	60	155	-49
Net Income / (Loss) Attributable to Noncontrolling Interest	0.38	-2.90	-3.94	-0.49	3.06	-1.57	0.63	2.77	3.76	0.26	4.13
Basic Earnings per Share	$1.33	$2.82	$1.72	($2.29)	$1.41	$3.09	$3.07	($3.28)	($2.08)	($7.08)	$6.64
Weighted Average Basic Shares Outstanding	32.87M	32.64M	31.66M	31.29M	30.95M	30.79M	27.18M	26.00M	26.09M	26.25M	26.15M
Diluted Earnings per Share	$1.28	$2.73	$1.64	($2.29)	$1.36	$3.00	$3.00	$0.00	($2.08)	($7.08)	$6.43
Weighted Average Diluted Shares Outstanding	34.24M	33.82M	33.05M	31.29M	32.22M	31.66M	27.77M	0.00	26.09M	26.25M	27.00M
Weighted Average Basic & Diluted Shares Outstanding	32.90M	32.70M	31.60M	31.30M	31M	30.80M	25.89M	25.05M	26.14M	26.36M	25.07M

This table shows Cimpress' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Net Income / (Loss) Attributable to Common Shareholders	-31	-25	-140	-49	29	4.55	58	-3.98	115	-13	61
Consolidated Net Income / (Loss)	-32	-25	-139	-50	27	4.57	60	-5.18	118	-12	62
Net Income / (Loss) Continuing Operations	-31	-25	-139	-50	27	4.57	60	-5.18	118	-12	62
Total Pre-Tax Income	-28	-15	-12	-41	39	13	77	5.43	33	-3.39	83
Total Operating Income	-27	-18	34	-12	54	34	108	39	66	39	81
Total Gross Profit	340	326	390	347	376	359	458	376	404	382	450
Total Revenue	723	703	845	742	789	757	921	781	833	805	939
Operating Revenue	723	703	845	742	789	757	921	781	833	805	939
Total Cost of Revenue	382	378	455	395	413	399	463	405	428	423	489
Operating Cost of Revenue	382	378	455	395	413	399	463	405	428	423	489
Total Operating Expenses	367	344	356	359	322	324	350	337	338	343	369
Selling, General & Admin Expense	53	54	50	53	53	48	49	54	54	52	57
Marketing Expense	211	201	205	187	181	192	212	192	194	204	224
Research & Development Expense	80	74	78	78	72	74	80	84	84	82	83
Amortization Expense	13	12	12	11	11	9.89	9.18	6.92	5.46	5.16	5.12
Restructuring Charge	9.57	1.82	11	30	0.62	-0.33	0.48	0.13	0.15	0.10	0.16
Total Other Income / (Expense), net	-0.99	2.59	-46	-29	-15	-21	-31	-34	-33	-43	1.82
Interest Expense	24	25	29	31	22	28	30	30	32	31	30
Other Income / (Expense), net	23	27	-17	1.38	7.12	6.42	-0.39	-3.65	-0.79	-11	32
Income Tax Expense	3.69	9.37	126	8.48	12	8.12	17	11	-85	9.00	21
Net Income / (Loss) Attributable to Noncontrolling Interest	-1.27	0.70	1.46	-0.48	-1.41	0.02	2.15	-1.20	3.17	0.17	0.56
Basic Earnings per Share	($1.17)	($0.97)	($5.34)	($1.88)	$1.11	$0.17	$2.18	($0.15)	$4.44	($0.50)	$2.45
Weighted Average Basic Shares Outstanding	26.09M	26.18M	26.23M	26.27M	26.25M	26.47M	26.61M	26.22M	26.15M	25.17M	24.97M
Diluted Earnings per Share	($3.90)	($0.97)	($5.34)	($1.88)	$1.11	$0.17	$2.14	($0.15)	$4.27	($0.50)	$2.36
Weighted Average Diluted Shares Outstanding	26.09M	26.18M	26.23M	26.27M	26.25M	27.08M	27.18M	26.22M	27.00M	25.17M	25.91M
Weighted Average Basic & Diluted Shares Outstanding	26.14M	26.23M	26.24M	26.32M	26.36M	26.59M	26.64M	25.45M	25.07M	25.15M	24.82M

This table details how cash moves in and out of Cimpress' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	12	41	-26	-52	-76	-8.95	9.74	128	234	-147	73
Net Cash From Operating Activities	154	242	247	157	192	331	338	265	220	130	351
Net Cash From Continuing Operating Activities	154	262	247	157	192	331	316	251	220	137	350
Net Income / (Loss) Continuing Operations	43	89	50	-72	47	93	84	-82	-51	-186	178
Consolidated Net Income / (Loss)	43	89	50	-72	47	93	84	-82	-51	-186	178
Depreciation Expense	72	98	132	158	169	174	168	173	176	162	152
Non-Cash Adjustments To Reconcile Net Income	46	12	42	56	24	29	131	98	37	49	67
Changes in Operating Assets and Liabilities, net	-7.54	43	23	15	-48	35	-67	62	58	111	-47
Net Cash From Investing Activities	-307	-217	-266	-302	-11	-420	-67	-354	-4.00	-104	-55
Net Cash From Continuing Investing Activities	-307	-217	-266	-302	-11	-420	-67	-354	136	-102	-55
Purchase of Property, Plant & Equipment	-82	-93	-107	-111	-102	-119	-94	-99	-126	-112	-113
Acquisitions	-221	-124	-165	-205	-0.42	-290	-4.27	-53	75	0.50	-3.62
Purchase of Investments	-4.63	-	-	-	-	-12	30	-207	0.00	-84	0.00
Sale of Property, Plant & Equipment	-	0.00	0.00	4.51	0.89	0.64	1.64	5.70	38	4.66	24
Divestitures	-	-	0.00	0.00	94	0.00	-1.12	0.00	0.00	-4.13	0.00
Sale and/or Maturity of Investments	-	-	-	6.35	0.00	-	0.00	0.00	149	92	39
Other Investing Activities, net	1.01	0.00	6.11	3.89	-3.06	0.35	1.56	-0.27	0.62	0.28	0.00
Net Cash From Financing Activities	164	25	-5.34	105	-178	82	-258	224	-107	-177	-223
Net Cash From Continuing Financing Activities	164	47	-5.34	105	-249	82	-258	229	-107	-177	-223
Repayment of Debt	-276	-594	-445	-556	-1,313	-967	-1,362	-1,564	-16	-107	-246
Repurchase of Common Equity	-42	0.00	-153	-50	-96	-141	-627	-5.06	-2.17	-96	-157
Payment of Dividends	4.82	0.00	5.14	0.00	0.00	-3.38	-3.96	-4.75	-3.96	-3.65	-0.55
Issuance of Debt	483	643	598	738	1,206	1,143	1,764	1,815	0.00	48	206
Issuance of Common Equity	4.43	17	4.71	6.19	12	60	22	2.28	0.00	0.33	2.10
Other Financing Activities, net	-9.43	-40	-15	-34	14	-9.26	-52	-15	-84	-20	-27
Effect of Exchange Rate Changes	1.24	-8.92	-2.64	0.79	2.51	-1.87	-	2.97	-15	3.80	-0.09
Other Net Changes in Cash	-	-	0.00	-12	12	0.00	-3.58	-	0.00	0.00	0.00
Cash Interest Paid	6.45	8.52	38	45	57	64	73	117	98	114	132
Cash Income Taxes Paid	18	14	20	49	32	26	14	28	33	31	49

This table details how cash moves in and out of Cimpress' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Net Change in Cash & Equivalents	256	-145	-21	3.71	15	-3.64	148	-120	49	-51	71
Net Cash From Operating Activities	88	-25	81	13	62	42	175	8.43	125	4.38	177
Net Cash From Continuing Operating Activities	88	-25	81	13	69	42	177	8.43	125	4.64	176
Net Income / (Loss) Continuing Operations	-32	-25	-139	-50	27	4.57	60	-5.18	118	-12	62
Consolidated Net Income / (Loss)	-32	-25	-139	-50	27	4.57	60	-5.18	118	-12	62
Depreciation Expense	42	41	41	40	41	40	39	37	36	36	35
Non-Cash Adjustments To Reconcile Net Income	14	12	18	159	-139	5.48	13	31	20	6.59	17
Changes in Operating Assets and Liabilities, net	63	-53	161	-136	139	-7.73	64	-54	-49	-25	62
Net Cash From Investing Activities	45	-101	-5.53	-1.78	4.63	-11	-20	-14	-9.91	-26	-38
Net Cash From Continuing Investing Activities	185	-101	-5.53	-7.93	12	-11	-20	-14	-9.91	-26	-38
Purchase of Property, Plant & Equipment	-31	-27	-29	-40	-15	-37	-25	-26	-25	-32	-43
Purchase of Investments	-	-84	-	-	-	0.00	-	-	-	0.00	5.44
Sale of Property, Plant & Equipment	10	0.12	1.24	0.50	2.80	5.64	0.35	0.43	17	1.57	0.10
Net Cash From Financing Activities	-7.83	-12	-101	-13	-51	-35	-12	-110	-65	-35	-59
Net Cash From Continuing Financing Activities	-7.83	-12	-101	-13	-51	-35	-12	-110	-65	-35	-59
Repayment of Debt	-3.45	-17	0.29	-41	-49	-24	-8.55	-4.11	-210	-535	-48
Repurchase of Common Equity	-1.84	0.00	-96	-	-	0.00	-	-101	-56	-11	-46
Issuance of Debt	-	10	-	38	-	0.17	0.35	0.37	205	525	41
Issuance of Common Equity	-	0.00	-	-	0.33	0.08	0.01	0.69	1.33	1.00	0.37
Other Financing Activities, net	-2.53	-4.85	-2.01	-10	-2.91	-11	-3.90	-6.50	-4.99	-15	-6.03
Effect of Exchange Rate Changes	-9.08	-6.88	8.64	1.82	0.22	-	-	-3.63	-0.71	5.71	-8.82
Cash Interest Paid	35	15	36	20	43	24	42	24	42	35	20
Cash Income Taxes Paid	9.40	4.26	6.91	12	7.69	16	11	13	10	-1.83	13

This table presents Cimpress' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	989	1,300	1,464	1,680	1,652	1,868	1,815	2,182	2,168	1,855	1,892
Total Current Assets	158	216	201	246	239	240	248	528	626	441	458
Cash & Equivalents	63	104	77	26	44	35	45	183	277	130	204
Short-Term Investments	14	6.91	7.89	-	-	-	0.00	152	50	39	4.50
Accounts Receivable	24	32	32	49	56	61	35	51	64	67	65
Inventories, net	12	18	18	47	61	66	80	70	127	108	97
Prepaid Expenses	46	55	65	79	79	78	89	73	109	97	88
Plant, Property, & Equipment, net	352	468	493	512	484	491	339	329	287	288	265
Total Noncurrent Assets	479	616	770	922	929	1,137	1,228	1,325	1,255	1,126	1,169
Long-Term Investments	-	-	-	-	-	-	0.00	51	0.00	4.50	0.00
Goodwill	317	401	466	515	521	719	622	727	767	782	787
Intangible Assets	124	173	252	324	286	333	281	274	245	205	169
Noncurrent Deferred & Refundable Income Taxes	8.76	17	26	48	67	60	143	150	113	13	95
Other Noncurrent Operating Assets	29	25	26	35	55	26	182	124	130	123	118
Total Liabilities & Shareholders' Equity	989	1,300	1,464	1,680	1,652	1,868	1,815	2,182	2,168	1,855	1,892
Total Liabilities	745	993	1,232	1,559	1,472	1,673	2,153	2,561	2,531	2,467	2,419
Total Current Liabilities	242	306	336	449	481	521	487	638	693	645	664
Short-Term Debt	38	21	22	29	59	81	18	9.90	10	11	12
Accounts Payable	53	66	87	127	152	185	164	200	314	286	327
Accrued Expenses	121	173	179	176	187	195	211	248	254	257	246
Current Deferred Revenue	27	23	26	30	28	32	39	51	59	45	46
Other Current Liabilities	0.89	21	23	78	55	28	55	130	56	47	33
Total Noncurrent Liabilities	504	687	897	1,110	991	1,153	1,667	1,923	1,839	1,821	1,755
Long-Term Debt	410	493	657	848	768	942	1,416	1,733	1,676	1,627	1,592
Noncurrent Deferred & Payable Income Tax Liabilities	31	48	69	61	51	45	34	27	41	47	25
Other Noncurrent Operating Liabilities	63	146	170	201	172	166	217	163	122	147	138
Redeemable Noncontrolling Interest	11	58	65	45	86	63	69	71	131	11	23
Total Equity & Noncontrolling Interests	232	249	166	75	94	132	-407	-449	-495	-623	-550
Total Preferred & Common Equity	232	249	166	75	94	132	407	-449	-495	-623	-550
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	232	249	166	75	94	132	-407	-449	-495	-623	-550
Common Stock	311	325	336	362	396	412	-439	461	502	540	571
Retained Earnings	343	435	486	415	453	537	-618	530	414	235	273
Treasury Stock	-423	-412	-549	-588	-686	-737	1,376	-1,369	-1,364	-1,364	-1,364
Accumulated Other Comprehensive Income / (Loss)	2.11	-99	-108	-113	-70	-80	89	-71	-47	-35	-30
Noncontrolling Interest	0.00	0.51	0.35	0.21	0.29	-	-	-	0.00	0.46	0.63

This table presents Cimpress' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025
Total Assets	2,124	2,098	1,952	1,893	1,809	1,948	1,784	1,884	1,918
Total Current Assets	531	579	525	470	444	578	442	428	496
Cash & Equivalents	162	132	111	115	125	274	154	153	224
Short-Term Investments	96	102	85	68	23	17	6.50	0.00	0.00
Accounts Receivable	67	71	70	68	69	63	71	74	59
Inventories, net	98	154	141	116	114	105	96	110	103
Prepaid Expenses	109	121	118	103	113	119	114	91	109
Plant, Property, & Equipment, net	299	273	278	284	272	277	270	274	279
Total Noncurrent Assets	1,294	1,246	1,148	1,139	1,094	1,093	1,072	1,182	1,144
Long-Term Investments	12	22	17	6.47	0.00	0.00	0.00	0.00	0.00
Goodwill	788	748	777	787	772	791	779	805	778
Intangible Assets	264	230	225	215	191	188	176	169	158
Noncurrent Deferred & Refundable Income Taxes	113	114	9.52	10	12	12	9.44	97	90
Other Noncurrent Operating Assets	117	132	120	120	118	102	107	111	118
Total Liabilities & Shareholders' Equity	2,124	2,098	1,952	1,893	1,809	1,948	1,784	1,884	1,918
Total Liabilities	2,467	2,476	2,553	2,543	2,412	2,487	2,408	2,430	2,453
Total Current Liabilities	618	672	697	676	639	708	636	670	728
Short-Term Debt	11	9.90	10	11	11	11	11	11	9.63
Accounts Payable	230	285	319	264	264	344	269	298	341
Accrued Expenses	263	266	265	300	273	265	271	267	285
Current Deferred Revenue	60	54	49	55	49	45	50	52	48
Other Current Liabilities	55	56	55	46	42	42	35	43	44
Total Noncurrent Liabilities	1,849	1,804	1,856	1,868	1,773	1,779	1,772	1,760	1,725
Long-Term Debt	1,699	1,655	1,679	1,683	1,595	1,601	1,591	1,586	1,579
Noncurrent Deferred & Payable Income Tax Liabilities	31	48	47	44	49	45	47	24	23
Other Noncurrent Operating Liabilities	119	101	130	141	129	133	134	151	123
Redeemable Noncontrolling Interest	120	130	13	12	11	13	12	24	19
Total Equity & Noncontrolling Interests	-463	-508	-613	-662	-614	-552	-635	-570	-554
Total Preferred & Common Equity	-463	-508	-613	-662	-614	-553	-636	-571	-554
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-463	-508	-613	-662	-614	-553	-636	-571	-554
Common Stock	489	510	522	530	544	561	563	574	577
Retained Earnings	461	386	256	207	240	298	206	251	278
Treasury Stock	-1,364	-1,364	-1,364	-1,364	-1,364	-1,364	-1,364	-1,364	-1,364
Accumulated Other Comprehensive Income / (Loss)	-50	-40	-28	-35	-35	-47	-41	-32	-46
Noncontrolling Interest	-	-	-	0.54	0.56	0.63	0.62	0.73	0.78

This table displays calculated financial ratios and metrics derived from Cimpress' official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	8.80%	17.63%	19.67%	19.43%	21.41%	6.12%	-9.80%	3.81%	12.10%	6.65%	6.89%
EBITDA Growth	23.72%	56.67%	10.40%	-47.90%	148.47%	18.99%	-32.17%	12.39%	2.55%	-16.24%	68.19%
EBIT Growth	39.56%	81.16%	-10.45%	-133.89%	487.01%	38.98%	-58.52%	32.11%	4.42%	-30.30%	228.38%
NOPAT Growth	96.77%	23.48%	-30.85%	-153.64%	447.75%	8.32%	1,199.06%	-94.48%	-396.49%	115.65%	753.54%
Net Income Growth	47.16%	106.19%	-43.56%	-243.22%	164.80%	99.79%	-10.15%	-198.17%	38.67%	-267.24%	195.74%
EPS Growth	50.59%	113.28%	-39.93%	-239.63%	159.39%	120.59%	0.00%	-100.00%	0.00%	-240.38%	190.82%
Operating Cash Flow Growth	9.80%	57.42%	2.20%	-36.64%	22.71%	72.15%	2.22%	-21.64%	-17.23%	-40.65%	169.19%
Free Cash Flow Firm Growth	-826.07%	94.84%	-488.43%	-161.25%	158.39%	-221.08%	1,797.56%	-90.67%	-272.68%	166.80%	78.17%
Invested Capital Growth	67.66%	15.51%	16.01%	13.28%	3.06%	22.91%	-11.25%	-6.86%	1.77%	-14.33%	1.96%
Revenue Q/Q Growth	4.79%	2.91%	5.84%	4.15%	2.65%	1.61%	-9.01%	8.70%	3.13%	2.19%	1.35%
EBITDA Q/Q Growth	6.44%	1.73%	18.43%	-28.11%	18.08%	10.43%	-22.35%	7.23%	-4.09%	36.45%	-0.17%
EBIT Q/Q Growth	4.30%	-1.00%	38.72%	-276.81%	53.30%	20.27%	-46.32%	17.36%	-8.34%	605.58%	1.85%
NOPAT Q/Q Growth	14.55%	-5.07%	7.65%	-128.33%	87.33%	27.26%	646.98%	11.06%	-538.50%	341.09%	124.57%
Net Income Q/Q Growth	-3.60%	-5.88%	77.82%	-251.90%	161.18%	71.06%	-47.57%	-42.11%	41.29%	24.19%	104.33%
EPS Q/Q Growth	-1.54%	-5.86%	69.07%	-236.76%	161.54%	77.51%	-43.40%	100.00%	-182.87%	29.27%	-37.87%
Operating Cash Flow Q/Q Growth	14.10%	-2.45%	1.03%	-10.84%	8.22%	22.55%	-13.81%	-2.97%	23.34%	-16.64%	22.01%
Free Cash Flow Firm Q/Q Growth	-730.74%	75.05%	77.25%	10.96%	-8.76%	42.28%	442.55%	-28.66%	-266.49%	-19.52%	72.66%
Invested Capital Q/Q Growth	50.38%	32.38%	-0.70%	-4.23%	1.97%	-2.38%	-5.27%	1.43%	-9.29%	-0.10%	6.36%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	64.49%	61.95%	56.73%	51.44%	50.64%	49.06%	49.67%	49.54%	48.30%	46.73%	48.51%
EBITDA Margin	10.75%	14.32%	13.21%	5.76%	11.79%	13.23%	9.95%	10.77%	9.85%	7.74%	12.17%
Operating Margin	6.76%	6.45%	4.37%	-2.14%	6.09%	5.95%	2.26%	4.79%	1.64%	1.86%	7.51%
EBIT Margin	5.06%	7.79%	5.83%	-1.66%	5.28%	6.91%	3.18%	4.04%	3.77%	2.46%	7.56%
Profit (Net Income) Margin	3.41%	5.98%	2.82%	-3.38%	1.80%	3.40%	3.39%	-3.20%	-1.75%	-6.03%	5.40%
Tax Burden Percent	76.52%	89.53%	76.27%	91.03%	70.50%	73.66%	2,797.04%	129.74%	-541.96%	614.50%	138.43%
Interest Burden Percent	88.06%	85.66%	63.38%	224.44%	48.52%	66.77%	3.81%	-61.02%	8.58%	-39.87%	51.60%
Effective Tax Rate	18.71%	10.47%	23.73%	0.00%	29.50%	26.34%	-2,697.04%	0.00%	641.96%	0.00%	-38.43%
Return on Invested Capital (ROIC)	14.22%	13.01%	7.77%	-3.64%	11.73%	11.23%	140.18%	8.52%	-25.98%	4.34%	39.76%
ROIC Less NNEP Spread (ROIC-NNEP)	4.56%	13.80%	5.92%	-9.35%	3.65%	8.18%	15.52%	-3.78%	-10.82%	-11.66%	28.25%
Return on Net Nonoperating Assets (RNNOA)	5.78%	19.42%	10.95%	-37.38%	19.39%	38.61%	-257.35%	14.49%	39.61%	33.75%	-71.00%
Return on Equity (ROE)	20.00%	32.43%	18.72%	-41.02%	31.12%	49.84%	-117.17%	23.01%	13.64%	38.09%	-31.24%
Cash Return on Invested Capital (CROIC)	-36.34%	-1.39%	-7.06%	-16.09%	8.71%	-9.33%	152.10%	15.63%	-27.73%	19.78%	37.82%
Operating Return on Assets (OROA)	8.08%	10.18%	7.55%	-2.25%	8.21%	10.80%	4.28%	5.21%	5.00%	3.77%	13.29%
Return on Assets (ROA)	5.45%	7.80%	3.65%	-4.59%	2.81%	5.31%	4.56%	-4.13%	-2.33%	-9.23%	9.49%
Return on Common Equity (ROCE)	19.48%	28.34%	14.41%	-28.05%	17.45%	29.96%	-225.27%	27.52%	17.36%	43.66%	-32.20%
Return on Equity Simple (ROE_SIMPLE)	18.63%	35.88%	30.42%	-96.27%	49.95%	70.92%	20.61%	18.35%	10.22%	29.80%	-32.32%
Net Operating Profit after Tax (NOPAT)	70	86	60	-32	111	121	1,565	86	-256	40	342
NOPAT Margin	5.50%	5.77%	3.34%	-1.50%	4.29%	4.38%	63.09%	3.36%	-8.88%	1.30%	10.40%
Net Nonoperating Expense Percent (NNEP)	9.66%	-0.79%	1.85%	5.72%	8.08%	3.05%	124.66%	12.31%	-15.16%	16.00%	11.51%
Cost of Revenue to Revenue	35.51%	38.05%	43.27%	48.56%	49.36%	50.94%	50.33%	50.46%	51.70%	53.27%	51.49%
SG&A Expenses to Revenue	9.18%	9.57%	8.16%	9.72%	6.83%	5.91%	7.38%	7.60%	6.83%	6.79%	6.25%
R&D to Revenue	13.88%	12.50%	11.75%	11.39%	9.48%	8.61%	10.21%	9.82%	10.14%	9.81%	9.78%
Operating Expenses to Revenue	57.72%	55.50%	52.36%	53.58%	44.55%	43.11%	43.35%	44.74%	46.67%	44.87%	40.99%
Earnings before Interest and Taxes (EBIT)	64	116	104	-35	137	190	79	104	109	76	249
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	137	214	236	123	306	364	247	277	284	238	401
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	0.80	1.10	0.35	0.51	0.68
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	23.70	0.00	0.00	0.00	12.84
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	4.22%	0.00%	0.00%	0.00%	7.79%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	3.27	4.34	2.52	3.57	4.20
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	1.38	1.65	0.87	0.99	1.11
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	13.91	15.32	8.81	12.77	9.11
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	43.55	40.80	23.04	40.12	14.66
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	2.19	49.16	0.00	75.82	10.66
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	10.14	16.02	11.41	23.35	10.41
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	2.02	26.82	0.00	16.64	11.20
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.84	1.67	2.93	7.27	4.59	5.25	-4.24	-4.61	-4.64	-2.68	-3.05
Long-Term Debt to Equity	1.69	1.61	2.84	7.03	4.26	4.83	-4.18	-4.58	-4.61	-2.66	-3.02
Financial Leverage	1.27	1.41	1.85	4.00	5.31	4.72	-16.58	-3.83	-3.66	-2.90	-2.51
Leverage Ratio	3.67	4.16	5.13	8.93	11.08	9.39	-25.69	-5.58	-5.87	-4.12	-3.29
Compound Leverage Factor	3.23	3.56	3.25	20.04	5.38	6.27	-0.98	3.40	-0.50	1.64	-1.70
Debt to Total Capital	64.78%	62.60%	74.57%	87.90%	82.11%	84.00%	130.90%	127.73%	127.48%	159.62%	148.85%
Short-Term Debt to Total Capital	5.43%	2.56%	2.39%	2.90%	5.89%	6.67%	1.64%	0.73%	0.79%	1.04%	1.16%
Long-Term Debt to Total Capital	59.35%	60.04%	72.18%	85.00%	76.23%	77.33%	129.26%	127.00%	126.70%	158.58%	147.69%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1.61%	7.09%	7.22%	4.57%	8.58%	5.19%	6.31%	5.21%	9.94%	1.11%	2.19%
Common Equity to Total Capital	33.61%	30.31%	18.21%	7.52%	9.30%	10.82%	-37.20%	-32.94%	-37.42%	-60.73%	-51.04%
Debt to EBITDA	3.28	2.40	2.87	7.12	2.70	2.81	5.81	6.28	5.93	6.88	4.00
Net Debt to EBITDA	2.72	1.89	2.51	6.92	2.56	2.72	5.63	4.89	4.78	6.15	3.48
Long-Term Debt to EBITDA	3.01	2.30	2.78	6.89	2.51	2.59	5.74	6.25	5.89	6.83	3.97
Debt to NOPAT	6.42	5.96	11.38	-27.40	7.43	8.49	0.92	20.15	-6.58	40.83	4.69
Net Debt to NOPAT	5.32	4.68	9.95	-26.60	7.03	8.20	0.89	15.69	-5.30	36.51	4.08
Long-Term Debt to NOPAT	5.88	5.72	11.01	-26.50	6.90	7.82	0.90	20.04	-6.54	40.56	4.65
Altman Z-Score	0.00	0.00	0.00	0.00	0.00	0.00	1.43	2.28	1.97	2.22	2.80
Noncontrolling Interest Sharing Ratio	2.58%	12.60%	23.01%	31.61%	43.91%	39.89%	-92.27%	-19.57%	-27.32%	-14.65%	-3.07%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.65	0.71	0.60	0.55	0.50	0.46	0.51	0.83	0.90	0.68	0.69
Quick Ratio	0.41	0.47	0.35	0.17	0.21	0.18	0.16	0.60	0.56	0.37	0.41
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-178	-9.21	-54	-142	83	-100	1,699	158	-274	183	326
Operating Cash Flow to CapEx	187.78%	259.86%	231.70%	146.55%	190.63%	279.23%	364.64%	282.86%	247.79%	121.88%	391.13%
Free Cash Flow to Firm to Interest Expense	-23.26	-0.55	-1.42	-3.22	1.17	-1.58	22.40	0.95	-2.75	1.72	2.70
Operating Cash Flow to Interest Expense	20.03	14.49	6.48	3.56	2.73	5.24	4.46	1.58	2.21	1.23	2.91
Operating Cash Flow Less CapEx to Interest Expense	9.37	8.91	3.68	1.13	1.30	3.36	3.24	1.02	1.32	0.22	2.17
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.60	1.31	1.29	1.36	1.56	1.56	1.35	1.29	1.33	1.53	1.76
Accounts Receivable Turnover	55.78	53.69	55.47	52.75	49.74	47.32	52.11	60.42	50.41	46.93	49.90
Inventory Turnover	45.66	37.29	42.41	32.06	23.88	22.08	17.05	17.31	15.17	13.99	16.55
Fixed Asset Turnover	4.02	3.65	3.72	4.25	5.21	5.65	5.98	7.72	9.38	10.72	11.91
Accounts Payable Turnover	11.97	9.58	10.14	9.69	9.15	8.30	7.16	7.15	5.81	5.47	5.54
Days Sales Outstanding (DSO)	6.54	6.80	6.58	6.92	7.34	7.71	7.00	6.04	7.24	7.78	7.31
Days Inventory Outstanding (DIO)	7.99	9.79	8.61	11.38	15.28	16.53	21.41	21.09	24.06	26.09	22.06
Days Payable Outstanding (DPO)	30.49	38.08	35.99	37.67	39.90	43.96	51.00	51.07	62.79	66.69	65.94
Cash Conversion Cycle (CCC)	-15.95	-21.50	-20.80	-19.37	-17.28	-19.72	-22.59	-23.93	-31.49	-32.82	-36.57
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	615	711	825	934	963	1,183	1,050	978	996	853	870
Invested Capital Turnover	2.59	2.25	2.33	2.43	2.73	2.56	2.22	2.54	2.93	3.33	3.82
Increase / (Decrease) in Invested Capital	248	95	114	110	29	221	-133	-72	17	-143	17
Enterprise Value (EV)	0.00	0.00	0.00	0.00	0.00	0.00	3,433	4,250	2,506	3,042	3,649
Market Capitalization	0.00	0.00	0.00	0.00	0.00	0.00	1,976	2,822	1,016	1,566	2,230
Book Value per Share	$6.98	$7.59	$5.27	$2.41	$3.05	$4.29	($15.75)	($17.26)	($18.96)	($23.67)	($21.62)
Tangible Book Value per Share	($6.28)	($9.90)	($17.56)	($24.54)	($23.23)	($29.95)	($50.62)	($55.73)	($57.72)	($61.13)	($59.17)
Total Capital	692	821	910	997	1,007	1,219	1,095	1,364	1,323	1,026	1,078
Total Debt	448	514	679	877	827	1,024	1,434	1,742	1,686	1,638	1,604
Total Long-Term Debt	410	493	657	848	768	942	1,416	1,733	1,676	1,627	1,592
Net Debt	372	404	593	851	783	988	1,389	1,356	1,359	1,465	1,396
Capital Expenditures (CapEx)	82	93	107	107	101	119	93	94	89	107	90
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-122	-179	-199	-200	-227	-234	-265	-435	-383	-362	-402
Debt-free Net Working Capital (DFNWC)	-46	-69	-113	-175	-182	-199	-220	-100	-56	-194	-193
Net Working Capital (NWC)	-84	-90	-135	-203	-242	-280	-238	-110	-66	-204	-206
Net Nonoperating Expense (NNE)	27	-3.07	9.23	40	64	27	1,481	169	-206	226	165
Net Nonoperating Obligations (NNO)	372	404	593	813	783	988	1,389	1,356	1,359	1,465	1,396
Total Depreciation and Amortization (D&A)	72	98	132	158	169	174	168	173	176	162	152
Debt-free, Cash-free Net Working Capital to Revenue	-9.63%	-11.98%	-11.11%	-9.38%	-8.74%	-8.52%	-10.70%	-16.89%	-13.26%	-11.77%	-12.21%
Debt-free Net Working Capital to Revenue	-3.62%	-4.59%	-6.34%	-8.17%	-7.04%	-7.24%	-8.88%	-3.87%	-1.93%	-6.29%	-5.88%
Net Working Capital to Revenue	-6.58%	-6.00%	-7.56%	-9.53%	-9.32%	-10.19%	-9.61%	-4.26%	-2.29%	-6.63%	-6.26%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.33	$2.82	$1.72	($2.29)	$1.41	$3.09	$3.07	($2.99)	($2.08)	($7.08)	$6.64
Adjusted Weighted Average Basic Shares Outstanding	32.87M	32.64M	31.66M	31.29M	30.95M	30.79M	27.18M	26.00M	26.09M	26.25M	26.15M
Adjusted Diluted Earnings per Share	$1.28	$2.73	$1.64	($2.29)	$1.36	$3.00	$3.00	($2.99)	($2.08)	$0.00	$6.43
Adjusted Weighted Average Diluted Shares Outstanding	34.24M	33.82M	33.05M	31.29M	32.22M	31.66M	27.77M	26.00M	26.09M	0.00	27.00M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$3.09	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	32.37M	32.45M	31.59M	31.30M	30.89M	30.39M	25.89M	25.05M	26.14M	26.36M	25.07M
Normalized Net Operating Profit after Tax (NOPAT)	70	89	83	-6.61	88	135	49	88	43	75	173
Normalized NOPAT Margin	5.50%	5.96%	4.67%	-0.31%	3.41%	4.90%	1.96%	3.40%	1.48%	2.42%	5.27%
Pre Tax Income Margin	4.46%	6.68%	3.70%	-3.71%	2.56%	4.61%	0.12%	-2.47%	0.32%	-0.98%	3.90%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	8.38	6.97	2.73	-0.80	1.94	3.01	1.04	0.62	1.09	0.72	2.07
NOPAT to Interest Expense	9.10	5.16	1.56	-0.73	1.58	1.91	20.64	0.52	-2.58	0.38	2.84
EBIT Less CapEx to Interest Expense	-2.29	1.40	-0.06	-3.24	0.51	1.13	-0.18	0.06	0.20	-0.29	1.32
NOPAT Less CapEx to Interest Expense	-1.57	-0.41	-1.23	-3.16	0.15	0.03	19.42	-0.04	-3.47	-0.63	2.10
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-11.13%	0.00%	-10.20%	0.00%	0.00%	3.61%	4.71%	-5.76%	-7.84%	-1.97%	0.31%
Augmented Payout Ratio	85.87%	0.00%	294.23%	-69.26%	204.87%	154.54%	751.25%	-11.90%	-12.12%	-53.43%	88.63%

This table displays calculated financial ratios and metrics derived from Cimpress' official financial filings.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	13.80%	6.97%	-0.53%	12.89%	9.13%	7.66%	9.01%	5.18%	5.55%	6.30%	1.93%
EBITDA Growth	-24.08%	-32.42%	-60.41%	5.07%	166.46%	59.73%	156.53%	151.15%	-0.66%	-21.21%	1.00%
EBIT Growth	-169.37%	-68.68%	-83.62%	32.86%	1,605.70%	329.68%	562.84%	428.90%	7.42%	-31.27%	4.98%
NOPAT Growth	-401.15%	33.82%	-64.24%	57.11%	299.32%	197.61%	258.26%	-338.58%	521.03%	124.31%	-28.44%
Net Income Growth	52.74%	-398.81%	-346.72%	28.73%	185.90%	118.47%	143.49%	89.60%	331.64%	-371.04%	2.26%
EPS Growth	-665.22%	-273.08%	-356.73%	0.00%	128.46%	117.53%	140.07%	92.02%	284.68%	-394.12%	10.28%
Operating Cash Flow Growth	89.79%	-169.05%	-43.40%	126.14%	-29.61%	267.34%	115.65%	-33.11%	102.37%	-89.62%	0.90%
Free Cash Flow Firm Growth	-146.41%	-233.57%	1,293.08%	253.72%	596.72%	367.11%	8.98%	-100.54%	21.17%	-107.56%	-92.73%
Invested Capital Growth	1.77%	5.92%	-13.72%	-22.21%	-14.33%	-17.00%	-10.63%	-4.24%	1.96%	4.88%	6.06%
Revenue Q/Q Growth	9.95%	-2.69%	20.16%	-12.19%	6.29%	-4.00%	21.67%	-15.28%	6.66%	-3.32%	16.67%
EBITDA Q/Q Growth	38.85%	31.75%	13.28%	-49.30%	252.12%	-21.02%	81.92%	-50.36%	39.28%	-37.36%	133.21%
EBIT Q/Q Growth	74.86%	332.72%	71.64%	-166.85%	663.87%	-33.59%	164.78%	-66.83%	84.17%	-57.51%	304.45%
NOPAT Q/Q Growth	4.40%	33.91%	286.89%	-136.32%	544.24%	-67.63%	585.91%	-144.47%	729.05%	-88.31%	118.84%
Net Income Q/Q Growth	54.40%	22.37%	-459.96%	64.05%	154.96%	-83.31%	1,218.76%	-108.60%	2,380.76%	-110.48%	597.54%
EPS Q/Q Growth	0.00%	46.70%	-450.52%	64.79%	159.04%	-84.68%	1,158.82%	-107.01%	2,946.67%	-111.71%	572.00%
Operating Cash Flow Q/Q Growth	282.22%	-128.75%	421.28%	-84.47%	390.63%	-31.64%	314.03%	-95.18%	1,384.45%	-96.50%	3,926.44%
Free Cash Flow Firm Q/Q Growth	76.24%	-93.00%	331.73%	44.65%	-23.22%	3.78%	-5.45%	-100.72%	17,297.90%	-106.47%	190.94%
Invested Capital Q/Q Growth	-9.29%	3.51%	-15.07%	-2.44%	-0.10%	0.28%	-8.56%	4.53%	6.36%	3.15%	-7.53%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	47.10%	46.30%	46.12%	46.79%	47.70%	47.34%	49.70%	48.16%	48.57%	47.48%	47.90%
EBITDA Margin	5.29%	7.16%	6.75%	3.90%	12.91%	10.62%	15.89%	9.31%	12.15%	7.88%	15.74%
Operating Margin	-3.76%	-2.55%	3.97%	-1.64%	6.83%	4.50%	11.69%	5.03%	7.97%	4.89%	8.62%
EBIT Margin	-0.56%	1.34%	1.92%	-1.46%	7.73%	5.35%	11.64%	4.56%	7.87%	3.46%	11.99%
Profit (Net Income) Margin	-4.41%	-3.52%	-16.39%	-6.71%	3.47%	0.60%	6.54%	-0.66%	14.19%	-1.54%	6.56%
Tax Burden Percent	113.11%	160.91%	1,116.27%	120.50%	70.38%	36.00%	78.20%	-95.43%	355.10%	365.42%	74.44%
Interest Burden Percent	695.41%	-163.05%	-76.68%	382.02%	63.76%	31.32%	71.82%	15.26%	50.77%	-12.17%	73.49%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	29.62%	64.00%	21.80%	195.43%	-255.10%	0.00%	25.56%
Return on Invested Capital (ROIC)	-7.70%	-5.24%	8.62%	-3.55%	16.02%	5.39%	35.40%	-18.65%	108.14%	13.04%	26.74%
ROIC Less NNEP Spread (ROIC-NNEP)	-8.65%	-6.12%	-3.00%	-6.36%	15.27%	4.85%	33.69%	-16.46%	99.94%	10.29%	26.84%
Return on Net Nonoperating Assets (RNNOA)	31.67%	22.49%	9.31%	18.84%	-44.22%	-14.18%	-82.70%	38.06%	-251.15%	-25.98%	-67.12%
Return on Equity (ROE)	23.96%	17.25%	17.93%	15.29%	-28.20%	-8.79%	-47.29%	19.41%	-143.00%	-12.94%	-40.39%
Cash Return on Invested Capital (CROIC)	-27.73%	-4.88%	11.76%	23.28%	19.78%	26.70%	21.98%	22.58%	37.82%	36.51%	32.63%
Operating Return on Assets (OROA)	-0.74%	1.84%	2.65%	-2.19%	11.84%	8.58%	19.17%	8.05%	13.83%	6.26%	20.83%
Return on Assets (ROA)	-5.85%	-4.82%	-22.71%	-10.07%	5.31%	0.97%	10.76%	-1.17%	24.94%	-2.78%	11.40%
Return on Common Equity (ROCE)	30.51%	22.08%	19.88%	17.32%	-32.33%	-10.06%	-48.40%	19.79%	-147.40%	-13.34%	-41.65%
Return on Equity Simple (ROE_SIMPLE)	0.00%	13.86%	43.22%	36.98%	0.00%	25.47%	-7.67%	-13.68%	0.00%	-28.17%	-29.26%
Net Operating Profit after Tax (NOPAT)	-19	-13	24	-8.54	38	12	84	-37	236	28	60
NOPAT Margin	-2.63%	-1.79%	2.78%	-1.15%	4.81%	1.62%	9.14%	-4.80%	28.29%	3.42%	6.42%
Net Nonoperating Expense Percent (NNEP)	0.95%	0.88%	11.62%	2.80%	0.75%	0.54%	1.71%	-2.19%	8.21%	2.75%	-0.10%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	7.94%	-	-	-	5.82%
Cost of Revenue to Revenue	52.90%	53.70%	53.88%	53.21%	52.30%	52.66%	50.30%	51.84%	51.43%	52.52%	52.10%
SG&A Expenses to Revenue	7.36%	7.69%	5.89%	7.08%	6.69%	6.38%	5.30%	6.95%	6.53%	6.45%	6.06%
R&D to Revenue	11.07%	10.59%	9.20%	10.55%	9.10%	9.82%	8.68%	10.73%	10.08%	10.17%	8.82%
Operating Expenses to Revenue	50.78%	48.85%	42.15%	48.43%	40.87%	42.84%	38.02%	43.13%	40.61%	42.60%	39.29%
Earnings before Interest and Taxes (EBIT)	-4.05	9.43	16	-11	61	41	107	36	66	28	113
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	38	50	57	29	102	80	146	73	101	63	148
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.35	0.22	0.25	0.38	0.51	0.59	0.66	0.73	0.68	0.61	0.54
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	50.53	26.95	12.84	13.11	11.31
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.98%	3.71%	7.79%	7.63%	8.84%
Enterprise Value to Invested Capital (EV/IC)	2.52	2.11	2.53	3.12	3.57	3.88	4.43	4.66	4.20	3.93	3.84
Enterprise Value to Revenue (EV/Rev)	0.87	0.74	0.76	0.88	0.99	1.06	1.08	1.17	1.11	1.05	0.95
Enterprise Value to EBITDA (EV/EBITDA)	8.81	8.37	12.78	15.27	12.77	12.35	9.68	9.50	9.11	9.18	8.28
Enterprise Value to EBIT (EV/EBIT)	23.04	24.73	406.14	248.14	40.12	31.01	17.49	15.59	14.66	14.90	13.19
Enterprise Value to NOPAT (EV/NOPAT)	0.00	251.07	0.00	0.00	75.82	43.30	38.88	25.00	10.66	9.74	10.27
Enterprise Value to Operating Cash Flow (EV/OCF)	11.41	13.81	23.17	17.06	23.35	16.76	11.88	13.26	10.41	11.26	10.14
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	19.91	11.74	16.64	13.17	19.02	20.20	11.20	11.01	12.13
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-4.64	-4.41	-2.81	-2.61	-2.68	-2.66	-2.99	-2.57	-3.05	-2.92	-2.97
Long-Term Debt to Equity	-4.61	-4.38	-2.80	-2.59	-2.66	-2.65	-2.97	-2.55	-3.02	-2.90	-2.95
Financial Leverage	-3.66	-3.67	-3.10	-2.96	-2.90	-2.92	-2.45	-2.31	-2.51	-2.52	-2.50
Leverage Ratio	-5.87	-5.72	-4.70	-4.04	-4.12	-3.99	-3.42	-2.89	-3.29	-3.21	-3.60
Compound Leverage Factor	-40.79	9.32	3.61	-15.45	-2.63	-1.25	-2.46	-0.44	-1.67	0.39	-2.65
Debt to Total Capital	127.48%	129.36%	155.19%	162.28%	159.62%	160.10%	150.17%	163.70%	148.85%	152.03%	150.76%
Short-Term Debt to Total Capital	0.79%	0.77%	0.94%	1.03%	1.04%	1.08%	1.03%	1.12%	1.16%	1.00%	0.91%
Long-Term Debt to Total Capital	126.70%	128.59%	154.25%	161.26%	158.58%	159.01%	149.13%	162.59%	147.69%	151.03%	149.85%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	9.94%	10.10%	1.15%	1.20%	1.11%	1.14%	1.31%	1.30%	2.19%	2.35%	1.85%
Common Equity to Total Capital	-37.42%	-39.46%	-56.34%	-63.48%	-60.73%	-61.23%	-51.47%	-65.01%	-51.04%	-54.39%	-52.61%
Debt to EBITDA	5.93	6.39	9.75	9.70	6.88	5.98	4.51	3.99	4.00	4.16	4.13
Net Debt to EBITDA	4.78	5.41	8.52	8.61	6.15	5.43	3.69	3.59	3.48	3.76	3.54
Long-Term Debt to EBITDA	5.89	6.36	9.69	9.64	6.83	5.94	4.48	3.96	3.97	4.13	4.10
Debt to NOPAT	-6.58	191.88	-60.31	-101.77	40.83	20.97	18.10	10.50	4.69	4.41	5.12
Net Debt to NOPAT	-5.30	162.33	-52.69	-90.36	36.51	19.04	14.82	9.45	4.08	3.99	4.40
Long-Term Debt to NOPAT	-6.54	190.74	-59.95	-101.12	40.56	20.83	17.97	10.43	4.65	4.39	5.09
Altman Z-Score	1.80	1.77	1.78	1.87	2.20	2.32	2.48	2.51	2.48	2.36	2.44
Noncontrolling Interest Sharing Ratio	-27.32%	-27.97%	-10.83%	-13.32%	-14.65%	-14.41%	-2.33%	-1.99%	-3.07%	-3.14%	-3.12%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.90	0.86	0.75	0.70	0.68	0.69	0.82	0.70	0.69	0.64	0.68
Quick Ratio	0.56	0.45	0.38	0.37	0.37	0.34	0.50	0.36	0.41	0.34	0.39
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-36	-70	163	235	181	187	177	-1.27	219	-14	13
Operating Cash Flow to CapEx	432.76%	-93.64%	296.03%	31.63%	487.04%	134.88%	700.20%	33.61%	1,510.08%	14.61%	410.54%
Free Cash Flow to Firm to Interest Expense	-1.51	-2.83	5.69	7.71	8.17	6.74	5.86	-0.04	6.78	-0.45	0.43
Operating Cash Flow to Interest Expense	3.64	-1.02	2.84	0.41	2.80	1.52	5.79	0.28	3.88	0.14	5.91
Operating Cash Flow Less CapEx to Interest Expense	2.80	-2.11	1.88	-0.89	2.22	0.39	4.96	-0.55	3.62	-0.82	4.47
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.33	1.37	1.39	1.50	1.53	1.60	1.65	1.77	1.76	1.81	1.74
Accounts Receivable Turnover	50.41	46.14	44.39	44.79	46.93	44.95	48.03	46.76	49.90	46.82	55.00
Inventory Turnover	15.17	12.54	13.18	15.03	13.99	12.42	13.62	15.79	16.55	15.32	16.78
Fixed Asset Turnover	9.38	9.87	10.10	10.34	10.72	11.52	11.56	11.72	11.91	12.24	12.09
Accounts Payable Turnover	5.81	6.07	5.30	6.52	5.47	6.05	5.04	6.30	5.54	6.12	5.10
Days Sales Outstanding (DSO)	7.24	7.91	8.22	8.15	7.78	8.12	7.60	7.81	7.31	7.80	6.64
Days Inventory Outstanding (DIO)	24.06	29.11	27.69	24.29	26.09	29.38	26.80	23.11	22.06	23.83	21.75
Days Payable Outstanding (DPO)	62.79	60.18	68.89	55.96	66.69	60.32	72.42	57.93	65.94	59.65	71.64
Cash Conversion Cycle (CCC)	-31.49	-23.16	-32.97	-23.52	-32.82	-22.83	-38.02	-27.01	-36.57	-28.03	-43.25
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	996	1,030	875	854	853	855	782	818	870	897	829
Invested Capital Turnover	2.93	2.93	3.10	3.09	3.33	3.32	3.87	3.89	3.82	3.81	4.17
Increase / (Decrease) in Invested Capital	17	58	-139	-244	-143	-175	-93	-36	17	42	47
Enterprise Value (EV)	2,506	2,178	2,213	2,666	3,042	3,315	3,463	3,811	3,649	3,521	3,188
Market Capitalization	1,016	640	724	1,150	1,566	1,846	2,129	2,358	2,230	2,053	1,804
Book Value per Share	($18.96)	($19.42)	($23.38)	($25.24)	($23.67)	($23.30)	($20.78)	($23.88)	($21.62)	($22.78)	($22.04)
Tangible Book Value per Share	($57.72)	($56.83)	($61.57)	($63.45)	($61.13)	($59.85)	($57.61)	($59.74)	($59.17)	($61.64)	($59.24)
Total Capital	1,323	1,287	1,089	1,043	1,026	1,003	1,074	978	1,078	1,050	1,054
Total Debt	1,686	1,664	1,689	1,693	1,638	1,606	1,612	1,602	1,604	1,596	1,589
Total Long-Term Debt	1,676	1,655	1,679	1,683	1,627	1,595	1,601	1,591	1,592	1,586	1,579
Net Debt	1,359	1,408	1,476	1,504	1,465	1,458	1,321	1,441	1,396	1,443	1,364
Capital Expenditures (CapEx)	20	27	27	40	13	31	25	25	8.28	30	43
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-383	-316	-358	-378	-362	-332	-410	-344	-402	-385	-447
Debt-free Net Working Capital (DFNWC)	-56	-82	-161	-195	-194	-184	-119	-183	-193	-232	-223
Net Working Capital (NWC)	-66	-92	-171	-205	-204	-195	-130	-194	-206	-242	-232
Net Nonoperating Expense (NNE)	13	12	162	41	11	7.71	24	-32	117	40	-1.35
Net Nonoperating Obligations (NNO)	1,359	1,408	1,476	1,504	1,465	1,458	1,321	1,441	1,396	1,443	1,364
Total Depreciation and Amortization (D&A)	42	41	41	40	41	40	39	37	36	36	35
Debt-free, Cash-free Net Working Capital to Revenue	-13.26%	-10.78%	-12.21%	-12.55%	-11.77%	-10.60%	-12.78%	-10.58%	-12.21%	-11.52%	-13.31%
Debt-free Net Working Capital to Revenue	-1.93%	-2.81%	-5.50%	-6.46%	-6.29%	-5.88%	-3.69%	-5.63%	-5.88%	-6.94%	-6.63%
Net Working Capital to Revenue	-2.29%	-3.15%	-5.85%	-6.82%	-6.63%	-6.23%	-4.04%	-5.96%	-6.26%	-7.25%	-6.91%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.17)	($0.97)	($5.34)	($1.88)	$1.11	$0.17	$2.18	($0.15)	$4.44	($0.50)	$2.45
Adjusted Weighted Average Basic Shares Outstanding	26.09M	26.18M	26.23M	26.27M	26.25M	26.47M	26.61M	26.22M	26.15M	25.17M	24.97M
Adjusted Diluted Earnings per Share	($3.90)	$0.00	($5.34)	$0.00	$1.11	$0.17	$2.14	($0.15)	$4.27	($0.50)	$2.36
Adjusted Weighted Average Diluted Shares Outstanding	26.09M	0.00	26.23M	0.00	26.25M	27.08M	27.18M	26.22M	27.00M	25.17M	25.91M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	26.14M	26.23M	26.24M	26.32M	26.36M	26.59M	26.64M	25.45M	25.07M	25.15M	24.82M
Normalized Net Operating Profit after Tax (NOPAT)	-12	-11	31	13	42	24	85	28	47	28	60
Normalized NOPAT Margin	-1.71%	-1.61%	3.71%	1.69%	5.36%	3.12%	9.18%	3.53%	5.59%	3.43%	6.43%
Pre Tax Income Margin	-3.90%	-2.19%	-1.47%	-5.57%	4.93%	1.68%	8.36%	0.70%	4.00%	-0.42%	8.81%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-0.17	0.38	0.57	-0.35	2.76	1.46	3.55	1.18	2.03	0.89	3.77
NOPAT to Interest Expense	-0.79	-0.51	0.82	-0.28	1.72	0.44	2.78	-1.24	7.30	0.88	2.02
EBIT Less CapEx to Interest Expense	-1.01	-0.71	-0.39	-1.66	2.19	0.33	2.72	0.35	1.77	-0.07	2.33
NOPAT Less CapEx to Interest Expense	-1.63	-1.59	-0.14	-1.59	1.14	-0.68	1.96	-2.07	7.04	-0.08	0.58
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-7.84%	-5.63%	-1.38%	-1.49%	-1.97%	-2.69%	1.30%	0.63%	0.31%	0.51%	0.51%
Augmented Payout Ratio	-12.12%	-5.63%	-38.13%	-41.26%	-53.43%	-63.79%	1.30%	116.46%	88.63%	104.75%	132.49%

Frequently Asked Questions About Cimpress' Financials

When does Cimpress's financial year end?

According to the most recent income statement we have on file, Cimpress' fiscal year ends in June. Their fiscal year 2024 ended on June 30, 2024.

How has Cimpress' net income changed over the last 10 years?

Cimpress' net income appears to be on a downward trend, with a most recent value of $177.81 million in 2024, rising from $43.32 million in 2014. The previous period was -$185.72 million in 2023.

What is Cimpress's operating income?

Cimpress's total operating income in 2024 was $247.35 million, based on the following breakdown:

Total Gross Profit: $1.60 billion
Total Operating Expenses: $1.35 billion

How has Cimpress revenue changed over the last 10 years?

Over the last 10 years, Cimpress' total revenue changed from $1.27 billion in 2014 to $3.29 billion in 2024, a change of 159.2%.

How much debt does Cimpress have?

Cimpress' total liabilities were at $2.42 billion at the end of 2024, a 1.9% decrease from 2023, and a 224.5% increase since 2014.

How much cash does Cimpress have?

In the past 10 years, Cimpress' cash and equivalents has ranged from $25.70 million in 2017 to $277.05 million in 2022, and is currently $203.78 million as of their latest financial filing in 2024.

How has Cimpress' book value per share changed over the last 10 years?

Over the last 10 years, Cimpress' book value per share changed from 6.98 in 2014 to -21.62 in 2024, a change of -409.5%.

Remove Ads

Related Companies

This page (NASDAQ:CMPR) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cimpress (CMPR) Financials

Frequently Asked Questions About Cimpress' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cimpress (CMPR) Financials

Annual Income Statements for Cimpress

Quarterly Income Statements for Cimpress

Annual Cash Flow Statements for Cimpress

Quarterly Cash Flow Statements for Cimpress

Annual Balance Sheets for Cimpress

Quarterly Balance Sheets for Cimpress

Annual Metrics and Ratios for Cimpress

Quarterly Metrics and Ratios for Cimpress

Frequently Asked Questions About Cimpress' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools